<DOC>
	<DOCNO>NCT00093912</DOCNO>
	<brief_summary>The purpose study establish safety clevidipine treatment perioperative hypertension . Approximately 250-500 patient perioperative hypertension undergo coronary artery bypass grafting ( CABG ) , off-pump coronary artery bypass ( OPCAB ) minimally invasive direct coronary artery bypass ( MIDCAB ) surgery and/or valve replacement/repair procedure anticipate randomly assign one two treatment group : clevidipine sodium nitroprusside .</brief_summary>
	<brief_title>Clevidipine Perioperative Treatment Hypertension ( ECLISPE-SNP )</brief_title>
	<detailed_description>The primary objective establish safety clevidipine treatment perioperative hypertension , assess compare incidence death , stroke , MI renal dysfunction clevidipine sodium nitroprusside treatment group initiation study drug infusion postoperative Day 30 . Secondary objective evaluate efficacy study drug , assess blood pressure ( BP ) lower effect additional safety variable .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Clevidipine</mesh_term>
	<mesh_term>Nitroprusside</mesh_term>
	<criteria>Prerandomization Provide write informed consent initiation study related procedure . Be least 18 year age Be schedule Coronary Artery Bypass Grafting ( CABG ) , Off Pump Coronary Artery Bypass ( OPCAB ) , Minimally Invasive Direct Coronary Artery Bypass ( MIDCAB ) surgery , and/or valve replacement/repair surgery Prerandomization Women childbearing potential ( unless negative pregnancy test ) Recent cerebrovascular accident ( within 3 month randomization ) Known intolerance calcium channel blocker Known suspect hypersensitivity sodium nitroprusside Allergy soybean oil egg lecithin ( component lipid vehicle ) Preexisting permanent ventricular pace Any disease condition , , judgment investigator would place patient undue risk enrol trial Participation another therapeutic drug therapeutic device trial within 30 day start study Postrandomization Determined hypertensive perioperatively determine investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Perioperative Hypertension</keyword>
</DOC>